• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 10/19/2018
Event Type  Injury  
Manufacturer Narrative
Device is combination product.
 
Event Description
(b)(6) clinical study.It was reported that patient experienced restenosis.In (b)(6) 2018, the patient qualifying condition was myocardial infarction (mi).They were referred for cardiac catheterization and index procedure was performed.The target lesion #1 was located in the proximal right coronary artery (rca) extending up to mid rca with 95% stenosis and was 20mm long, with a reference vessel diameter of 2.25mm.The target lesion #1 was treated with pre-dilatation and placement of a 2.25x24mm promus "priemiere" stent.Following this intervention, post dilatation was performed.The target lesion #2 was located in the distal rca with 95% stenosis and was 16mm long, with a reference vessel diameter of 2.25mm.The target lesion #2 was not treated with pre-dilatation and placement of a 2.25mmx20mm promus priemiere stent.Following this intervention, post dilatation was performed.Sixteen days later, the patient was discharged.In (b)(6) 2018, the patient was noted with restenosis in the right original coronary artery in the primary stent and was hospitalized for further evaluation and treatment.The patient was treated with balloon dilatation.Nineteen days later, the patient was discharged and on the same day, the event was considered to be resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8268755
MDR Text Key133791518
Report Number2134265-2019-00204
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 01/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/30/2018
Initial Date FDA Received01/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age68 YR
-
-